3 Undervalued Biotech Stocks With Upcoming Catalysts
March 15, 2016 at 16:31 PM EDT
New drug approvals and the rollout of just-commercialized products will be the catalysts that send these undervalued stocks rallying: DVAX, ACAD and RLYP.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.